
OR WAIT null SECS
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce - Biopharma Business News, Market Insights. All rights reserved.
Jay McHarg, CEO of AeroSafe Global, discusses the significance of rethinking the “last mile” as the first moment of patient care—using real-time Active Delivery Management—for proactive and improved pharmaceutical logistics.
Sponsored by AeroSafe Global
Jay McHarg, CEO of AeroSafe Global, defines success in pharmaceutical logistics as ensuring patients and providers receive what they need, when they need it—emphasizing that the “last mile” of delivery should be viewed as the first moment of patient care, not merely the final logistical step. This perspective introduces new performance metrics—on time, right product, at temperature, and 100% acceptance—that move beyond traditional supply chain measures such as fill rates and carrier pricing.
To achieve this, he explains that AeroSafe employs a system called Active Delivery Management, which replaces passive tracking (“let’s see what happens”) with proactive management based on real-time and forecasted data for Estimated Time of Arrival (ETA) and product temperature. Unlike standard tracking systems that monitor only location and timing, Active Delivery Management offers visibility into both current and predicted risks related to timing and thermal compliance.
At the core of this system is a proprietary thermal modeling engine, developed and calibrated over years using data on ambient conditions, transportation modes, and weather patterns. This model can estimate the internal package temperature within approximately 5% accuracy, enabling predictive insights days in advance. With live and forecasted time-and-temperature data, users can identify at-risk shipments early, take corrective action, notify patients or providers, and even intercept packages—ensuring that products outside specification never reach their destination.
Want to continue watching this interview? Click here.
Related Content: